The immunogenomic landscape of resected intrahepatic cholangiocarcinoma
Abstract
Cholangiocarcinoma (CCA) is a deadly and highly therapy‐refractory cancer of the bile ducts, with early results from immune checkpoint blockade trials showing limited responses. Whereas recent molecular assessments have made bulk characterizations of immune profiles and their genomic correlates, spatial assessments may reveal actionable insights.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 06, 2021
- Source ID
- 10.1002/hep.32150
Entities
People
- Ahmed Shalaby
- Anil Korkut
- Behnaz Bozorgui
- Fernando Carapeto
- Funda Meric‐bernstam
- Ignacio Wistuba
- Lawrence N. Kwong
- Luisa Solis Soto
- Milind Javle
- Rachna T. Shroff
- Sharmeen Chagani
- Wai Chin Foo
Organizations
- University of Arizona
- University of Texas at Austin